Tamer Group

Established in 1922 as the first pharmacy in Saudi Arabia, Tamer Group has evolved into a diversified conglomerate with interests spanning healthcare, pharmaceuticals, medical devices, nutrition, e-commerce, logistics, and consumer goods. The company operates across the Middle East and North Africa (MENA) region, offering a comprehensive portfolio of products and services that contribute to personal wellness and public health. Tamer Group's commitment to excellence and patient care has made it a trusted name in the industry, with a team of over 4,000 employees dedicated to delivering high-quality solutions tailored to meet the unique needs of each individual. Tamer Group's investment strategy focuses on sectors such as healthcare, pharmaceuticals, medical devices, nutrition, e-commerce, logistics, and consumer goods. The company actively seeks opportunities in early-stage, growth, and late-stage investments, with investment sizes ranging from $1 million to $50 million. Geographically, Tamer Group concentrates its investments in the MENA region, including countries like Saudi Arabia, the United Arab Emirates, Kuwait, Bahrain, Qatar, Oman, Jordan, Lebanon, Egypt, Iraq, Yemen, Syria, Palestine, Libya, Tunisia, Algeria, Morocco, Mauritania, Somalia, and Djibouti. This regional focus aligns with the company's mission to enhance healthcare and wellness across the MENA region. Over the years, Tamer Group has demonstrated a strong track record of growth and innovation. In 2023, the company broke ground for the construction of a logistics park to enhance its storage capacity and supply chain capabilities. In November 2023, Tamer Mölnlycke Care, a partnership between Tamer Group and Sweden-based Mölnlycke Health Care, announced the development of local products in Saudi Arabia. The company has a 21% market share in pharmaceutical distribution in Saudi Arabia. Tamer Group's dedication to corporate social responsibility is evident through its focus on health, education, and community initiatives, while emphasizing operational improvement and customer satisfaction to enhance healthcare in Saudi Arabia and the broader Middle East. Tamer Group's investment philosophy centers on creating shared value by empowering future generations and driving healthcare transformation. The company leverages its culture, talent, and governance to transform society through better health, reflecting the values of service, agility, and trust that guide it today. Supporting Saudi Arabia's Vision 2030 has long been part of Tamer Group's DNA, as evidenced by its partnerships with global pharmaceutical leaders and its focus on localizing products to meet regional needs. The company's evolution from a family pharmacy to a national conglomerate underscores its commitment to innovation and excellence in the healthcare sector.